M&A Outlook: European Healthcare

A closer look at an industry widely considered 'pandemic proof'

Despite the impact of COVID across sectors and the global market, transactions in healthcare – notably pharma, biotech and medtech – have continued to flourish, demonstrating the increasing importance of healthcare in such a climate.

What's inside:

Take a closer look at the current and future state of Healthcare M&A in Europe and the companies and firms at the forefront of this activity.


✅      Europe’s specialist VC firms have continued to successfully raise funds 

✅      High demand puts power in hands of Pharma and Biotech companies

✅      Medtech is on the rise amid a growing focus on digital health solutions

✅      Why M&A will be critical for accessing external innovation

✅      How Ansarada's advanced Virtual Data Room supports large healthcare transactions

Download the report